Home/Filings/4/0001437749-20-023244
4//SEC Filing

Hanna John Walter JR 4

Accession 0001437749-20-023244

CIK 0001384101other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 4:48 PM ET

Size

10.3 KB

Accession

0001437749-20-023244

Insider Transaction Report

Form 4
Period: 2020-11-06
Hanna John Walter JR
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-11-06$20.21/sh+21,250$429,46395,559 total
  • Sale

    Common Stock

    2020-11-06$43.40/sh20,050$870,07675,509 total
  • Sale

    Common Stock

    2020-11-06$44.19/sh1,200$53,03174,309 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-11-0621,25038,750 total
    Exercise: $20.21Exp: 2029-02-27Common Stock (21,250 underlying)
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 11, 2020.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $43.00 to $44.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $44.03 to $44.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]The option became exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001781127

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:48 PM ET
Size
10.3 KB